{"id":4765,"date":"2017-01-10T18:18:44","date_gmt":"2017-01-10T23:18:44","guid":{"rendered":"http:\/\/www.newlonkong.com\/English\/?p=4765"},"modified":"2017-01-10T18:19:14","modified_gmt":"2017-01-10T23:19:14","slug":"amag-pharmaceuticals-amag","status":"publish","type":"post","link":"https:\/\/www.newlonkong.com\/English\/amag-pharmaceuticals-amag\/","title":{"rendered":"AMAG Pharmaceuticals (AMAG)"},"content":{"rendered":"<h4 class=\"entry-title post-title\"><a href=\"http:\/\/www.newlonkong.com\/English\/markets\/new-york\/list-of-stocks-us\/amag-pharmaceuticals-amag\/\">AMAG Pharmaceuticals, Inc.,&nbsp;(AMAG)<\/a>, &nbsp;a specialty pharmaceutical company, provides products and services with a focus on maternal health, anemia management, and cancer supportive care in the United States. It markets Makena, a hydroxyprogesterone caproate injection to reduce the risk of preterm birth in women pregnant with a single baby who have a history of singleton spontaneous preterm birth; Feraheme (ferumoxytol) injection for use as an intravenous (IV) iron replacement therapy for the treatment of iron deficiency anemia in adult patients with chronic kidney disease; and MuGard Mucoadhesive Oral Wound Rinse for the management of oral mucocitis\/stomatiits and various types of oral wounds.<\/h4>\n","protected":false},"excerpt":{"rendered":"<p>AMAG Pharmaceuticals, Inc.,&nbsp;(AMAG), &nbsp;a specialty pharmaceutical company, provides products and services with a focus on maternal health, anemia management, and cancer supportive care in the United States. It markets Makena, a hydroxyprogesterone caproate injection to reduce the risk of preterm<span class=\"ellipsis\">&hellip;<\/span><\/p>\n<div class=\"read-more\"><a href=\"https:\/\/www.newlonkong.com\/English\/amag-pharmaceuticals-amag\/\">Read more &#8250;<\/a><\/div>\n<p><!-- end of .read-more --><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"ngg_post_thumbnail":0,"footnotes":""},"categories":[853,1],"tags":[656],"class_list":["post-4765","post","type-post","status-publish","format-standard","hentry","category-bio","category-uncategorized","tag-amag"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.newlonkong.com\/English\/wp-json\/wp\/v2\/posts\/4765","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newlonkong.com\/English\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newlonkong.com\/English\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newlonkong.com\/English\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newlonkong.com\/English\/wp-json\/wp\/v2\/comments?post=4765"}],"version-history":[{"count":1,"href":"https:\/\/www.newlonkong.com\/English\/wp-json\/wp\/v2\/posts\/4765\/revisions"}],"predecessor-version":[{"id":4766,"href":"https:\/\/www.newlonkong.com\/English\/wp-json\/wp\/v2\/posts\/4765\/revisions\/4766"}],"wp:attachment":[{"href":"https:\/\/www.newlonkong.com\/English\/wp-json\/wp\/v2\/media?parent=4765"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newlonkong.com\/English\/wp-json\/wp\/v2\/categories?post=4765"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newlonkong.com\/English\/wp-json\/wp\/v2\/tags?post=4765"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}